Global Valvular Heart Diseases Treatment Market Research and Forecast, 2018-2023
Valvular heart disease characterized by defect or any damage in one of the four heart valves, namely, mitral, aortic, tricuspid or pulmonary. The adult cardiac surgery such as treatment for valvular heart diseases is evolving at a rapid pace. The disease can be diagnosed by electrocardiogram, stress testing, cardiac catheterization, chest x-ray, and other diagnosis procedure. Moreover, the diseases can be treated by medication or surgery using endovascular techniques, minimally invasive and transcatheter valve therapies, and other devices and mechanical circulatory support. The valvular heart disease market is showing exponential growth due to the high incidence rate of concomitant coronary artery diseases coupled with the rising geriatric population. These diseases are mainly associated with the aging and the aortic stenosis and mitral regurgitation that majorly occur in an older population base. Furthermore, the changing lifestyle and the excessive consumption of alcohol are causing heart diseases and heart failure which is leading to the major growth in valvular heart diseases treatment market.
The heart treatments and the certification to perform it is very expensive and time-consuming process due to the stringent regulation of the government and medical authority. Additionally, the lack of expertise and medical practitioners for heart surgery or therapy can hinder the growth of the market. Whereas, the future of surgery for acquired heart disease is quite promising due to the rapid development of invasive cardiology and the adoption of minimally invasive techniques for heart surgery. And the continuous R&D in the field of valve replacement and adult cardiac surgery such as treatment for valvular heart diseases is evolving at a rapid pace. Improvement in healthcare infrastructure will create the huge opportunity for such treatment in market.
Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America is growing with significant growth and is dominating the overall global valvular heart diseases treatment market due to increased heart failure cases and the excessive consumption of alcohol. Europe is the second largest market due to the high adoption of minimally-invasive technology and technological advancement in the healthcare sector. The improvement in healthcare infrastructure and rising awareness of heart diseases and treatment is the driving factor for the growth of the valvular heart diseases market in the Asia-Pacific.
There are many companies which are operating in the global valvular heart diseases treatment market such as Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, PLC CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., and Micro Interventional Devices, Inc., among others. The companies are working on developing innovative valvular heart diseases treatment system through research and innovation, expansion, M&A, finding a new market or innovate in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of valvular heart diseases treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
MARKET SEGMENTATION
Global valvular heart diseases treatment market is segmented on the basis of regional outlook and following segments:
1. Global Valvular Heart Diseases Treatment Market Research and Analysis by Diseases
2. Global Valvular Heart Diseases Treatment Market Research and Analysis by Diagnosis
3. Global Valvular Heart Diseases Treatment Market Research and Analysis by Treatment
4. Global Valvular Heart Diseases Treatment Market Research and Analysis by End-Users
5. Global Valvular Heart Diseases Treatment Market Research and Analysis by Region
The report covers
The heart treatments and the certification to perform it is very expensive and time-consuming process due to the stringent regulation of the government and medical authority. Additionally, the lack of expertise and medical practitioners for heart surgery or therapy can hinder the growth of the market. Whereas, the future of surgery for acquired heart disease is quite promising due to the rapid development of invasive cardiology and the adoption of minimally invasive techniques for heart surgery. And the continuous R&D in the field of valve replacement and adult cardiac surgery such as treatment for valvular heart diseases is evolving at a rapid pace. Improvement in healthcare infrastructure will create the huge opportunity for such treatment in market.
Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America is growing with significant growth and is dominating the overall global valvular heart diseases treatment market due to increased heart failure cases and the excessive consumption of alcohol. Europe is the second largest market due to the high adoption of minimally-invasive technology and technological advancement in the healthcare sector. The improvement in healthcare infrastructure and rising awareness of heart diseases and treatment is the driving factor for the growth of the valvular heart diseases market in the Asia-Pacific.
There are many companies which are operating in the global valvular heart diseases treatment market such as Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, PLC CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., and Micro Interventional Devices, Inc., among others. The companies are working on developing innovative valvular heart diseases treatment system through research and innovation, expansion, M&A, finding a new market or innovate in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of valvular heart diseases treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market
- Authentic Public Databases such as the OECD, WHO, and others
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION
Global valvular heart diseases treatment market is segmented on the basis of regional outlook and following segments:
1. Global Valvular Heart Diseases Treatment Market Research and Analysis by Diseases
2. Global Valvular Heart Diseases Treatment Market Research and Analysis by Diagnosis
3. Global Valvular Heart Diseases Treatment Market Research and Analysis by Treatment
4. Global Valvular Heart Diseases Treatment Market Research and Analysis by End-Users
5. Global Valvular Heart Diseases Treatment Market Research and Analysis by Region
The report covers
- Comprehensive research methodology of global valvular heart diseases treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global valvular heart diseases treatment market.
- Insights about market determinants which are stimulating the global valvular heart diseases treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
1.2.4. Exceptions
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Patent Analysis
2.3. Analyst Insights & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendation
2.3.3. Conclusion
2.4. Rules & Regulation
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Higher Incidence of Concomitant Coronary Artery Diseases
3.1.2. Changing Lifestyle and Excessive Consumption of Alcohol
3.1.3. Increasing Cases of Endocarditis
3.1.4. Rising Incidence of Heart Diseases or Heart Attack
3.2. Restraints
3.2.1. High Cost of Certification and Treatment
3.2.2. Lack of Skilled Professional
3.3. Opportunities
3.3.1. Rapid Development of Invasive Cardiology
3.3.2. Increasing Adoption of Minimally Invasive Technique
3.3.3. Improvement in Healthcare Infrastructure
3.3.4. Continuous R&D of Valve Repair and Replacement Procedure
4. MARKET SEGMENTATION
4.1. Global Valvular Heart Diseases Treatment Market by Diseases
4.1.1. Aortic Valve Replacement
4.1.2. Heart Valve Disease
4.1.3. Mitral Valve Stenosis
4.1.4. Others (Tricuspid Valve Disorders)
4.2. Global Valvular Heart Diseases Treatment Market by Diagnosis
4.2.1. Cardiac Catheterization
4.2.2. Electrocardiogram (ECG)
4.2.3. Chest X-Ray
4.2.4. Stress Testing
4.2.5. Others
4.3. Global Valvular Heart Diseases Treatment Market by Treatment
4.3.1. Medication
4.3.2. Surgery
4.3.2.1. Valve Repair
4.3.2.2. Valve Replacement
4.4. Global Valvular Heart Diseases Treatment Market by End-Users
4.4.1. Hospital & Clinics
4.4.2. Ambulatory Surgical Centers
4.4.3. Research Institutes
5. COMPETITIVE LANDSCAPE
5.1. Key Strategy Analysis
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)
7. COMPANY PROFILES
7.1. Abbott Laboratories
7.2. B. Braun Melsungen AG
7.3. Biotronik SE & Co. KG
7.4. Boston Scientific Corp.
7.5. Braile Biomédica
7.6. C. R. Bard, Inc.
7.7. Cardiac Dimensions Pty. Ltd.
7.8. CardiaMed
7.9. Cardiosolutions, Inc.
7.10. Cook Group Inc.
7.11. CryoLife, Inc.
7.12. Edwards Lifesciences Corp.
7.13. HLT, Inc.
7.14. InterValve Medical Inc.
7.15. JenaValve Technology, Inc.
7.16. Labcor Laboratórios Ltd.
7.17. Lepu Medical Technology (Beijing) Co., Ltd.
7.18. LivaNova PLC
7.19. Medtronic, PLC
7.20. Micro Interventional Devices, Inc.
7.21. NeoChord, Inc.
7.22. Neovasc Inc.
7.23. ON-X Life Technologies Inc.
7.24. Osypka Medical GmbH
7.25. Siemens Healthcare Medical Solutions Ltd.
7.26. Terumo Corp.
7.27. Toray Industries, Inc.
7.28. TTK Healthcare Ltd.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
1.2.4. Exceptions
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Patent Analysis
2.3. Analyst Insights & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendation
2.3.3. Conclusion
2.4. Rules & Regulation
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Higher Incidence of Concomitant Coronary Artery Diseases
3.1.2. Changing Lifestyle and Excessive Consumption of Alcohol
3.1.3. Increasing Cases of Endocarditis
3.1.4. Rising Incidence of Heart Diseases or Heart Attack
3.2. Restraints
3.2.1. High Cost of Certification and Treatment
3.2.2. Lack of Skilled Professional
3.3. Opportunities
3.3.1. Rapid Development of Invasive Cardiology
3.3.2. Increasing Adoption of Minimally Invasive Technique
3.3.3. Improvement in Healthcare Infrastructure
3.3.4. Continuous R&D of Valve Repair and Replacement Procedure
4. MARKET SEGMENTATION
4.1. Global Valvular Heart Diseases Treatment Market by Diseases
4.1.1. Aortic Valve Replacement
4.1.2. Heart Valve Disease
4.1.3. Mitral Valve Stenosis
4.1.4. Others (Tricuspid Valve Disorders)
4.2. Global Valvular Heart Diseases Treatment Market by Diagnosis
4.2.1. Cardiac Catheterization
4.2.2. Electrocardiogram (ECG)
4.2.3. Chest X-Ray
4.2.4. Stress Testing
4.2.5. Others
4.3. Global Valvular Heart Diseases Treatment Market by Treatment
4.3.1. Medication
4.3.2. Surgery
4.3.2.1. Valve Repair
4.3.2.2. Valve Replacement
4.4. Global Valvular Heart Diseases Treatment Market by End-Users
4.4.1. Hospital & Clinics
4.4.2. Ambulatory Surgical Centers
4.4.3. Research Institutes
5. COMPETITIVE LANDSCAPE
5.1. Key Strategy Analysis
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)
7. COMPANY PROFILES
7.1. Abbott Laboratories
7.2. B. Braun Melsungen AG
7.3. Biotronik SE & Co. KG
7.4. Boston Scientific Corp.
7.5. Braile Biomédica
7.6. C. R. Bard, Inc.
7.7. Cardiac Dimensions Pty. Ltd.
7.8. CardiaMed
7.9. Cardiosolutions, Inc.
7.10. Cook Group Inc.
7.11. CryoLife, Inc.
7.12. Edwards Lifesciences Corp.
7.13. HLT, Inc.
7.14. InterValve Medical Inc.
7.15. JenaValve Technology, Inc.
7.16. Labcor Laboratórios Ltd.
7.17. Lepu Medical Technology (Beijing) Co., Ltd.
7.18. LivaNova PLC
7.19. Medtronic, PLC
7.20. Micro Interventional Devices, Inc.
7.21. NeoChord, Inc.
7.22. Neovasc Inc.
7.23. ON-X Life Technologies Inc.
7.24. Osypka Medical GmbH
7.25. Siemens Healthcare Medical Solutions Ltd.
7.26. Terumo Corp.
7.27. Toray Industries, Inc.
7.28. TTK Healthcare Ltd.
LIST OF TABLES
TABLE # 1 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL AORTIC VALVE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL HEART VALVE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL MITRAL VALVE STENOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL CARDIAC CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL ELECTROCARDIOGRAM (ECG) MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL CHEST X-RAY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL STRESS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL HOSPITAL & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 24 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 25 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 26 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 27 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 28 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 29 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 30 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 31 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 32 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY, TREATMENT 2017-2023 ($ MILLION)
TABLE # 33 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2023($ MILLION)
TABLE # 34 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 35 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 36 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 37 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 38 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2023($ MILLION)
TABLE # 1 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL AORTIC VALVE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL HEART VALVE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL MITRAL VALVE STENOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL CARDIAC CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL ELECTROCARDIOGRAM (ECG) MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL CHEST X-RAY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL STRESS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL HOSPITAL & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 24 NORTH AMERICA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 25 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 26 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 27 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 28 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 29 EUROPE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 30 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 31 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 32 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY, TREATMENT 2017-2023 ($ MILLION)
TABLE # 33 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2023($ MILLION)
TABLE # 34 ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 35 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASES, 2017-2023 ($ MILLION)
TABLE # 36 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 37 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 38 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2023($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY DISEASES, 2017 VS 2023 ($ MILLION)
FIGURE # 2 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY DIAGNOSIS, 2017 VS 2023 ($ MILLION)
FIGURE # 3 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY TREATMENT, 2017 VS 2023 ($ MILLION)
FIGURE # 4 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE, BY END-USERS, 2017 VS 2023 ($ MILLION)
FIGURE # 5 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 ($ MILLION)
FIGURE # 6 US VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 7 CANADA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 8 UK VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 11 FRANCE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 12 ITALY VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 13 ROE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 15 INDIA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 16 JAPAN VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 18 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY DISEASES, 2017 VS 2023 ($ MILLION)
FIGURE # 2 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY DIAGNOSIS, 2017 VS 2023 ($ MILLION)
FIGURE # 3 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY TREATMENT, 2017 VS 2023 ($ MILLION)
FIGURE # 4 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE, BY END-USERS, 2017 VS 2023 ($ MILLION)
FIGURE # 5 GLOBAL VALVULAR HEART DISEASES TREATMENT MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 ($ MILLION)
FIGURE # 6 US VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 7 CANADA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 8 UK VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 11 FRANCE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 12 ITALY VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 13 ROE VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 15 INDIA VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 16 JAPAN VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF ASIA-PACIFIC VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 18 ROW VALVULAR HEART DISEASES TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
